Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Allogeneic
1.2.3 Autologous
1.3 Market by Application
1.3.1 Global Chimeric Antigen Receptor T Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Universities and Colleges
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Perspective (2018-2033)
2.2 Chimeric Antigen Receptor T Cell Therapy Growth Trends by Region
2.2.1 Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Region (2024-2033)
2.3 Chimeric Antigen Receptor T Cell Therapy Market Dynamics
2.3.1 Chimeric Antigen Receptor T Cell Therapy Industry Trends
2.3.2 Chimeric Antigen Receptor T Cell Therapy Market Drivers
2.3.3 Chimeric Antigen Receptor T Cell Therapy Market Challenges
2.3.4 Chimeric Antigen Receptor T Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chimeric Antigen Receptor T Cell Therapy Players by Revenue
3.1.1 Global Top Chimeric Antigen Receptor T Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Chimeric Antigen Receptor T Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chimeric Antigen Receptor T Cell Therapy Revenue
3.4 Global Chimeric Antigen Receptor T Cell Therapy Market Concentration Ratio
3.4.1 Global Chimeric Antigen Receptor T Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor T Cell Therapy Revenue in 2022
3.5 Chimeric Antigen Receptor T Cell Therapy Key Players Head office and Area Served
3.6 Key Players Chimeric Antigen Receptor T Cell Therapy Product Solution and Service
3.7 Date of Enter into Chimeric Antigen Receptor T Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chimeric Antigen Receptor T Cell Therapy Breakdown Data by Type
4.1 Global Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Type (2024-2033)
5 Chimeric Antigen Receptor T Cell Therapy Breakdown Data by Application
5.1 Global Chimeric Antigen Receptor T Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Chimeric Antigen Receptor T Cell Therapy Market Size (2018-2033)
6.2 North America Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023)
6.4 North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chimeric Antigen Receptor T Cell Therapy Market Size (2018-2033)
7.2 Europe Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023)
7.4 Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size (2018-2033)
8.2 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size (2018-2033)
9.2 Latin America Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size (2018-2033)
10.2 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Detail
11.1.2 Amgen Business Overview
11.1.3 Amgen Chimeric Antigen Receptor T Cell Therapy Introduction
11.1.4 Amgen Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.1.5 Amgen Recent Development
11.2 Bellicum Pharmaceuticals
11.2.1 Bellicum Pharmaceuticals Company Detail
11.2.2 Bellicum Pharmaceuticals Business Overview
11.2.3 Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Introduction
11.2.4 Bellicum Pharmaceuticals Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.2.5 Bellicum Pharmaceuticals Recent Development
11.3 Bluebird Bio
11.3.1 Bluebird Bio Company Detail
11.3.2 Bluebird Bio Business Overview
11.3.3 Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Introduction
11.3.4 Bluebird Bio Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.3.5 Bluebird Bio Recent Development
11.4 Caribou Biosciences
11.4.1 Caribou Biosciences Company Detail
11.4.2 Caribou Biosciences Business Overview
11.4.3 Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Introduction
11.4.4 Caribou Biosciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.4.5 Caribou Biosciences Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Introduction
11.5.4 Celgene Corporation Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.5.5 Celgene Corporation Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Detail
11.6.2 Cellectis Business Overview
11.6.3 Cellectis Chimeric Antigen Receptor T Cell Therapy Introduction
11.6.4 Cellectis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.6.5 Cellectis Recent Development
11.7 Celyad Oncology
11.7.1 Celyad Oncology Company Detail
11.7.2 Celyad Oncology Business Overview
11.7.3 Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Introduction
11.7.4 Celyad Oncology Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.7.5 Celyad Oncology Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Detail
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Introduction
11.8.4 Gilead Sciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.8.5 Gilead Sciences Recent Development
11.9 Intellia Therapeutics
11.9.1 Intellia Therapeutics Company Detail
11.9.2 Intellia Therapeutics Business Overview
11.9.3 Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Introduction
11.9.4 Intellia Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.9.5 Intellia Therapeutics Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Detail
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Introduction
11.10.4 Johnson & Johnson Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.10.5 Johnson & Johnson Recent Development
11.11 Legend Biotech
11.11.1 Legend Biotech Company Detail
11.11.2 Legend Biotech Business Overview
11.11.3 Legend Biotech Chimeric Antigen Receptor T Cell Therapy Introduction
11.11.4 Legend Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.11.5 Legend Biotech Recent Development
11.12 Merck
11.12.1 Merck Company Detail
11.12.2 Merck Business Overview
11.12.3 Merck Chimeric Antigen Receptor T Cell Therapy Introduction
11.12.4 Merck Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.12.5 Merck Recent Development
11.13 Noile-Immune Biotech
11.13.1 Noile-Immune Biotech Company Detail
11.13.2 Noile-Immune Biotech Business Overview
11.13.3 Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Introduction
11.13.4 Noile-Immune Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.13.5 Noile-Immune Biotech Recent Development
11.14 Novartis
11.14.1 Novartis Company Detail
11.14.2 Novartis Business Overview
11.14.3 Novartis Chimeric Antigen Receptor T Cell Therapy Introduction
11.14.4 Novartis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.14.5 Novartis Recent Development
11.15 Pfizer
11.15.1 Pfizer Company Detail
11.15.2 Pfizer Business Overview
11.15.3 Pfizer Chimeric Antigen Receptor T Cell Therapy Introduction
11.15.4 Pfizer Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.15.5 Pfizer Recent Development
11.16 Sangamo Therapeutics
11.16.1 Sangamo Therapeutics Company Detail
11.16.2 Sangamo Therapeutics Business Overview
11.16.3 Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Introduction
11.16.4 Sangamo Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.16.5 Sangamo Therapeutics Recent Development
11.17 Servier Laboratories
11.17.1 Servier Laboratories Company Detail
11.17.2 Servier Laboratories Business Overview
11.17.3 Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Introduction
11.17.4 Servier Laboratories Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
11.17.5 Servier Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Allogeneic
Table 3. Key Players of Autologous
Table 4. Global Chimeric Antigen Receptor T Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2018-2023)
Table 8. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2024-2033)
Table 10. Chimeric Antigen Receptor T Cell Therapy Market Trends
Table 11. Chimeric Antigen Receptor T Cell Therapy Market Drivers
Table 12. Chimeric Antigen Receptor T Cell Therapy Market Challenges
Table 13. Chimeric Antigen Receptor T Cell Therapy Market Restraints
Table 14. Global Chimeric Antigen Receptor T Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Players (2018-2023)
Table 16. Global Top Chimeric Antigen Receptor T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor T Cell Therapy as of 2022)
Table 17. Ranking of Global Top Chimeric Antigen Receptor T Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Chimeric Antigen Receptor T Cell Therapy Product Solution and Service
Table 21. Date of Enter into Chimeric Antigen Receptor T Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Type (2024-2033)
Table 27. Global Chimeric Antigen Receptor T Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global Chimeric Antigen Receptor T Cell Therapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Chimeric Antigen Receptor T Cell Therapy Revenue Market Share by Application (2024-2033)
Table 31. North America Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. Amgen Company Detail
Table 47. Amgen Business Overview
Table 48. Amgen Chimeric Antigen Receptor T Cell Therapy Product
Table 49. Amgen Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 50. Amgen Recent Development
Table 51. Bellicum Pharmaceuticals Company Detail
Table 52. Bellicum Pharmaceuticals Business Overview
Table 53. Bellicum Pharmaceuticals Chimeric Antigen Receptor T Cell Therapy Product
Table 54. Bellicum Pharmaceuticals Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 55. Bellicum Pharmaceuticals Recent Development
Table 56. Bluebird Bio Company Detail
Table 57. Bluebird Bio Business Overview
Table 58. Bluebird Bio Chimeric Antigen Receptor T Cell Therapy Product
Table 59. Bluebird Bio Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 60. Bluebird Bio Recent Development
Table 61. Caribou Biosciences Company Detail
Table 62. Caribou Biosciences Business Overview
Table 63. Caribou Biosciences Chimeric Antigen Receptor T Cell Therapy Product
Table 64. Caribou Biosciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 65. Caribou Biosciences Recent Development
Table 66. Celgene Corporation Company Detail
Table 67. Celgene Corporation Business Overview
Table 68. Celgene Corporation Chimeric Antigen Receptor T Cell Therapy Product
Table 69. Celgene Corporation Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 70. Celgene Corporation Recent Development
Table 71. Cellectis Company Detail
Table 72. Cellectis Business Overview
Table 73. Cellectis Chimeric Antigen Receptor T Cell Therapy Product
Table 74. Cellectis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 75. Cellectis Recent Development
Table 76. Celyad Oncology Company Detail
Table 77. Celyad Oncology Business Overview
Table 78. Celyad Oncology Chimeric Antigen Receptor T Cell Therapy Product
Table 79. Celyad Oncology Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 80. Celyad Oncology Recent Development
Table 81. Gilead Sciences Company Detail
Table 82. Gilead Sciences Business Overview
Table 83. Gilead Sciences Chimeric Antigen Receptor T Cell Therapy Product
Table 84. Gilead Sciences Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 85. Gilead Sciences Recent Development
Table 86. Intellia Therapeutics Company Detail
Table 87. Intellia Therapeutics Business Overview
Table 88. Intellia Therapeutics Chimeric Antigen Receptor T Cell Therapy Product
Table 89. Intellia Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 90. Intellia Therapeutics Recent Development
Table 91. Johnson & Johnson Company Detail
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Chimeric Antigen Receptor T Cell Therapy Product
Table 94. Johnson & Johnson Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Legend Biotech Company Detail
Table 97. Legend Biotech Business Overview
Table 98. Legend Biotech Chimeric Antigen Receptor T Cell Therapy Product
Table 99. Legend Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 100. Legend Biotech Recent Development
Table 101. Merck Company Detail
Table 102. Merck Business Overview
Table 103. Merck Chimeric Antigen Receptor T Cell Therapy Product
Table 104. Merck Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 105. Merck Recent Development
Table 106. Noile-Immune Biotech Company Detail
Table 107. Noile-Immune Biotech Business Overview
Table 108. Noile-Immune Biotech Chimeric Antigen Receptor T Cell Therapy Product
Table 109. Noile-Immune Biotech Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 110. Noile-Immune Biotech Recent Development
Table 111. Novartis Company Detail
Table 112. Novartis Business Overview
Table 113. Novartis Chimeric Antigen Receptor T Cell Therapy Product
Table 114. Novartis Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 115. Novartis Recent Development
Table 116. Pfizer Company Detail
Table 117. Pfizer Business Overview
Table 118. Pfizer Chimeric Antigen Receptor T Cell Therapy Product
Table 119. Pfizer Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 120. Pfizer Recent Development
Table 121. Sangamo Therapeutics Company Detail
Table 122. Sangamo Therapeutics Business Overview
Table 123. Sangamo Therapeutics Chimeric Antigen Receptor T Cell Therapy Product
Table 124. Sangamo Therapeutics Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 125. Sangamo Therapeutics Recent Development
Table 126. Servier Laboratories Company Detail
Table 127. Servier Laboratories Business Overview
Table 128. Servier Laboratories Chimeric Antigen Receptor T Cell Therapy Product
Table 129. Servier Laboratories Revenue in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023) & (US$ Million)
Table 130. Servier Laboratories Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chimeric Antigen Receptor T Cell Therapy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Type: 2022 VS 2033
Figure 3. Allogeneic Features
Figure 4. Autologous Features
Figure 5. Global Chimeric Antigen Receptor T Cell Therapy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Application: 2022 VS 2033
Figure 7. Hospitals Case Studies
Figure 8. Universities and Colleges Case Studies
Figure 9. Others Case Studies
Figure 10. Chimeric Antigen Receptor T Cell Therapy Report Years Considered
Figure 11. Global Chimeric Antigen Receptor T Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 12. Global Chimeric Antigen Receptor T Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 13. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Region: 2022 VS 2033
Figure 14. Global Chimeric Antigen Receptor T Cell Therapy Market Share by Players in 2022
Figure 15. Global Top Chimeric Antigen Receptor T Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chimeric Antigen Receptor T Cell Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Chimeric Antigen Receptor T Cell Therapy Revenue in 2022
Figure 17. North America Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 18. North America Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2018-2033)
Figure 19. United States Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Canada Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2018-2033)
Figure 23. Germany Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. France Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. U.K. Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Italy Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Russia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Nordic Countries Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Chimeric Antigen Receptor T Cell Therapy Market Share by Region (2018-2033)
Figure 31. China Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Japan Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. South Korea Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Southeast Asia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. India Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Australia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2018-2033)
Figure 39. Mexico Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Brazil Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Chimeric Antigen Receptor T Cell Therapy Market Share by Country (2018-2033)
Figure 43. Turkey Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Saudi Arabia Chimeric Antigen Receptor T Cell Therapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Amgen Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 46. Bellicum Pharmaceuticals Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 47. Bluebird Bio Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 48. Caribou Biosciences Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 49. Celgene Corporation Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 50. Cellectis Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 51. Celyad Oncology Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 52. Gilead Sciences Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 53. Intellia Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 54. Johnson & Johnson Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 55. Legend Biotech Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 56. Merck Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 57. Noile-Immune Biotech Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 58. Novartis Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 59. Pfizer Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 60. Sangamo Therapeutics Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 61. Servier Laboratories Revenue Growth Rate in Chimeric Antigen Receptor T Cell Therapy Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed